PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA, USA.\', \'Vaccine and Immunotherapy Center (VIC), MGH and HMS, Boston, MA, USA.\', \'Division of Allergy, Immunology and Rheumatology, MGH and HMS, Boston, MA, USA.\', \'Special Advisor to the Assistant Secretary of Public Health Preparedness and Response U.S Dept of Health and Human Services, Washington, DC, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1096/fj.202000919
?:doi
?:hasPublicationType
?:journal
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
is ?:pmid of
?:pmid
?:pmid
  • 32350928
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rethinking the role of hydroxychloroquine in the treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32350928>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32350928>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all